FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards

Nov.06.2024
FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
The new Fumot Tornado 4-in-1 e-cigarette from FUMOT is now available on UK sites like Vapesourcing and Powervapeshop. The product complies with EU TPD standards and offers approximately 4,000 puffs.

Recently, 2Firsts noted that FUMOT's new 4-in-1 product, the Fumot Tornado 4in1, has been listed on the brand's official website as well as on UK e-cigarette distributor sites like Vapesourcing and Powervapeshop. The product complies with TPD standards and offers approximately 4,000 puffs.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Fumot Tornado 4in1 | Image source: vapesourcing

 

Specifically, the features of the Fumot Tornado 4in1 include:

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Mapping: 2Firsts

 

At the InterTabac tobacco exhibition held in September, the FUMOT brand was interviewed by the 2Firsts team. Brand representatives said, "New large disposable products that meet TPD standards are emerging," and emphasized the importance of actively complying with regulatory standards for long-term stability. The brand also launched several innovative products, such as "2+10," at the exhibition to meet the demands of the German market.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT brand products are listed on the vapesourcing website|Image source: vapesourcing

 

According to observations by 2Firsts, websites that offer online sales of FUMOT e-cigarettes in the UK are relatively limited. FUMOT products were not found on popular sites such as VapeUK, VapeClub, eCigaretteDirect, and ZeroVapes. However, on sites like Vapesourcing and PowerVapeShop, where FUMOT products are available, the offerings mainly consist of high-puff disposable e-cigarettes.

 

In a review article on the Fumot Tornado 4in1 by the e-cigarette website *Planet of the Vapes*, it was noted: “They [referring to the FUMOT brand] have many devices that do not comply with TPD (Tobacco Products Directive) regulations, but also a few that do, which is why their business is global.”

 

“Some of the flavors [of the Fumot Tornado 4in1] are indeed well-blended.”

 

“Since they are 4-in-1, you might find a flavor in the pack you purchase that you don’t enjoy.”

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of the Fumot Tornado 4in1 released by planetofthevapes|Image source planetofthevapes

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
Review article of Fumot Tornado 4in1 published by Planet of the Vapes | Image source: Planet of the Vapes

 

It is worth noting that on FUMOT’s official website, a separate “TPD Series” section is listed under the product category, featuring products compliant with TPD standards. This series includes low-puff disposables, open systems, refillable models, and 4-in-1 multi-flavor devices.

 

FUMOT launches 4-in-1 e-cigarette in UK, meeting TPD standards
FUMOT official website TPD Series | Image source: FUMOT official website

 

2Firsts will continue to monitor the latest e-cigarette products and market trends globally, providing the public with accurate and authoritative industry information.

 


 

2Firsts' product column remains committed to delivering readers the latest product updates in the new tobacco field. We invite readers to submit insights and news on e-cigarette developments.

 

For unique perspectives or information, feel free to contact us at carrie.cai@2firsts.com or scan the QR code below.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Bets on Age-Gating and 678 PMTA Assets as U.S. Vape Enforcement Landscape Shifts
Charlie’s Holdings said in its latest shareholder letter that it is moving to commercialize PACHA products and monetize its PMTA assets as the FDA changes enforcement priorities for unauthorized ENDS products. Thirty PACHA SKUs were previously tentatively identified for a proposed public list of products that the FDA generally does not intend to prioritize for enforcement. Charlie’s is also preparing test-market sales of age-gated flavored disposables and says it currently holds 678 PMTA-related product assets while seeking additional strategic transactions and partnerships.
Sep.11
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona Turns to a 50% Retail Vape Tax as Tobacco Tax Revenue Falls 47% From 2008
Arizona's First Things First is pushing for an excise tax equal to 50% of the retail price of vaping products, estimating that the measure could generate about $100 million annually. The agency says its tobacco-tax revenue has fallen 47% from 2008 levels. Arizona has attempted to broaden its nicotine tax base in each of the past two years: a 2025 bill proposed a 50% wholesale-price tax, while a 2026 measure shifted to a 50% retail-price tax covering alternative nicotine products and vapor products. Separately, the state enacted HB 4001 this year to establish a new licensing and sales framework for alternative nicotine products.
Sep.21
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06